EP
NUVB icon

Essential Partners’s Nuvation Bio NUVB Stock Holding History

Essential Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.04K Hold
1,435
– – ﹤0.01% 1296
2026
Q2 		$8.15K Buy
1,435
+153
+12% +$748 ﹤0.01% 1315
2026
Q1 		$5.5K Sell
1,282
-1
-0.1% -$6 ﹤0.01% 1529
2025
Q4 		$11.5K Buy
1,283
+13
+1% +$81 ﹤0.01% 1117
2025
Q3 		$4.7K Buy
1,270
+929
+272% +$2.53K ﹤0.01% 1448
2025
Q2 		$665 Buy
+341
New +$710 ﹤0.01% 1622

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return
EWA
Emergent Wealth Advisors Williamsville, New York $191M AUM 17.3% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Essential Partners's NUVB Position: Q3 2026 in Review

Essential Partners held its Nuvation Bio (NUVB) position steady in Q3 2026 at 1,435 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Essential Partners first reported a position in NUVB in Q2 2025 and has held it in 6 quarters since. The position peaked at $11.5K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Essential Partners held 1,435 shares of Nuvation Bio worth $8.04K as of Q3 2026.
  • Essential Partners left its Nuvation Bio share count unchanged in Q3 2026.
  • Nuvation Bio made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1296 holding.
  • Essential Partners first reported a position in Nuvation Bio in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Nuvation Bio position peaked at $11.5K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.